Central Nervous System Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/central-nervous-system/ The leading site for news and procurement in the pharmaceutical industry Tue, 16 Apr 2024 10:21:03 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Central Nervous System Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/central-nervous-system/ 32 32 FDA halts Neumora’s schizophrenia drug trial over convulsions in rabbits https://www.pharmaceutical-technology.com/news/fda-halts-neumoras-schizophrenia-drug-trial-over-convulsions-in-rabbits/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2242616675.jpg Tue, 16 Apr 2024 10:09:59 +0000 https://www.pharmaceutical-technology.com/?p=296761 Norgine seeks approval for high-risk neuroblastoma treatment https://www.pharmaceutical-technology.com/news/norgine-high-risk-neuroblastoma/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Norgine.jpg Tue, 16 Apr 2024 08:00:10 +0000 https://www.pharmaceutical-technology.com/news/norgine-high-risk-neuroblastoma/ Lonza links with NeuroSense to detect exosome-based biomarkers https://www.pharmaceutical-technology.com/news/lonza-neurosense-exosome-biomarkers/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Lonza.jpg Wed, 10 Apr 2024 10:15:38 +0000 https://www.pharmaceutical-technology.com/news/lonza-neurosense-exosome-biomarkers/ Seaport emerges after $100m raise with ex-Karuna team at helm https://www.pharmaceutical-technology.com/news/seaport-emerges-after-100m-raise-with-ex-karuna-team-at-helm/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2221260019.jpg Tue, 09 Apr 2024 15:57:54 +0000 https://www.pharmaceutical-technology.com/news/seaport-emerges-after-100m-raise-with-ex-karuna-team-at-helm/ FDA gives nod to BrainStorm for ALS trial after Phase III flop https://www.pharmaceutical-technology.com/news/brainstorm-new-trial-agree-fda-after-failure/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2152815119.jpg Tue, 09 Apr 2024 14:23:13 +0000 https://www.pharmaceutical-technology.com/uncategorized/brainstorm-new-trial-agree-fda-after-failure/ Acumen and Lonza to produce Alzheimer’s drug sabirnetug https://www.pharmaceutical-technology.com/news/acumen-lonza-alzheimers-sabirnetug/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Acumen.jpg Fri, 05 Apr 2024 10:14:05 +0000 https://www.pharmaceutical-technology.com/news/acumen-lonza-alzheimers-sabirnetug/ MiNA and Nippon Shinyaku enter RNAa therapeutics deal https://www.pharmaceutical-technology.com/news/mina-nippon-rnaa-therapeutics/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Nippon.jpg Fri, 05 Apr 2024 10:06:04 +0000 https://www.pharmaceutical-technology.com/news/mina-nippon-rnaa-therapeutics/ Addex spinoff Neurosterix debuts with $63m for developing neurological therapies https://www.pharmaceutical-technology.com/news/addex-spinoff-neurosterix-debuts-with-63m-for-developing-neurological-therapies/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2052824726-scaled.jpg Thu, 04 Apr 2024 14:20:54 +0000 https://www.pharmaceutical-technology.com/news/addex-spinoff-neurosterix-debuts-with-63m-for-developing-neurological-therapies/ Otsuka and Lundbeck’s schizophrenia treatment gains EC approval https://www.pharmaceutical-technology.com/news/otsuka-lundbeck-schizophrenia/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/Otsuka.jpg Thu, 28 Mar 2024 09:37:03 +0000 https://www.pharmaceutical-technology.com/news/otsuka-lundbeck-schizophrenia/ AriBio licenses Alzheimer’s pill in China for up to $770m https://www.pharmaceutical-technology.com/news/aribio-licenses-alzheimers-pill-in-china-for-up-to-770m/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/shutterstock_2034265133.jpg Mon, 25 Mar 2024 11:39:21 +0000 https://www.pharmaceutical-technology.com/news/aribio-licenses-alzheimers-pill-in-china-for-up-to-770m/